Katrin Rapakko

发表

Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients

U. Olsson‐Strömberg, S. Mustjoki, T. Fioretos, 2013, Leukemia.

Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph+CD34+CD38neg) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy

S. Mustjoki, K. Porkka, T. Lundán, 2010, Leukemia.